Macrophage 12/15 lipoxygenase expression increases plasma and hepatic lipid levels and exacerbates atherosclerosis
12/15 lipoxygenase (12/15LO) oxidizes polyunsaturated fatty acids (PUFAs) to form bioactive lipid mediators. The role of 12/15LO in atherosclerosis development remains controversial. We evaluated atherosclerosis development and lipid metabolism in 12/15LO-LDL receptor (LDLr) double knockout (DK) vs....
Main Authors: | Shunxing Rong, Qiang Cao, Mingxia Liu, Jeongmin Seo, Lin Jia, Elena Boudyguina, Abraham K. Gebre, Perry L. Colvin, Thomas L. Smith, Robert C. Murphy, Nilamadhab Mishra, John S. Parks |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-04-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520405620 |
Similar Items
-
AIBP protects against metabolic abnormalities and atherosclerosis[S]
by: Dina A. Schneider, et al.
Published: (2018-01-01) -
CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice[S]
by: Fatiha Nassir, et al.
Published: (2013-11-01) -
Evaluation of Risk Factors for Hepatosteatosis in Gall Stone Disease
by: Osman Anıl Savaş, et al.
Published: (2015-09-01) -
The Prevalence of Hepatosteatosis in Patients with Diabetes
by: Deniz Gökalp, et al.
Published: (2007-01-01) -
Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice
by: Marta López-Parra, et al.
Published: (2008-12-01)